Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HR18042 for Postoperative Pain of Impacted Tooth
NCT04812860Phase 2Completed
- Sponsor
- Hengrui
- Start
- Dec 2020
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of HR18042 in postoperative pain (5 arms), sponsored by Hengrui. Primary endpoint: Sum of Pain Intensity Differences. Started Dec 2020; status: completed.
02
Drugs
HR18042
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04812860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04812860.